Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: NANOPARTÍCULAS, RATOS, METOTREXATO
ABNT
MARANHÃO, Raul Cavalcante et al. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2017APA
Maranhão, R. C., Marques, A. F., Guido, M. C., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, & Salemi, V. M. C. (2017). Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. Clare: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 out. 31 ]Vancouver
Maranhão RC, Marques AF, Guido MC, Tavares ER, Bispo DL, Melo MDT de, Salemi VMC. Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats. Atherosclerosis. 2017 ; 263 e48 res. SAG052.[citado 2024 out. 31 ]